Adenosine diphosphate sugar pyrophosphatase prevents glycogen biosynthesis in Escherichia coli by Moreno Bruna, Beatriz et al.
Adenosine diphosphate sugar pyrophosphatase
prevents glycogen biosynthesis in
Escherichia coli
Beatriz Moreno-Bruna*, Edurne Baroja-Ferna´ndez*, Francisco Jose´ Mun˜oz, Ainara Bastarrica-Berasategui,
Aitor Zandueta-Criado, Milagros Rodri´guez-Lo´pez, In˜igo Lasa, Takashi Akazawa, and Javier Pozueta-Romero†
Instituto de Agrobiotecnologı´a y Recursos Naturales, Universidad Pu´blica de NavarrayConsejo Superior de Investigaciones Cientı´ficas, Ctra. de Mutilva syn,
Mutilva Baja 31192 Navarra, Spain
Communicated by Roland Douce, Universite de Grenoble, Grenoble, France, April 27, 2001 (received for review February 18, 2001)
An adenosine diphosphate sugar pyrophosphatase (ASPPase, EC
3.6.1.21) has been characterized by using Escherichia coli. This
enzyme, whose activities in the cell are inversely correlated with
the intracellular glycogen content and the glucose concentration in
the culture medium, hydrolyzes ADP-glucose, the precursor mol-
ecule of glycogen biosynthesis. ASPPase was purified to apparent
homogeneity (over 3,000-fold), and sequence analyses revealed
that it is a member of the ubiquitously distributed group of
nucleotide pyrophosphatases designated as ‘‘nudix’’ hydrolases.
Insertional mutagenesis experiments leading to the inactivation of
the ASPPase encoding gene, aspP, produced cells with marginally
low enzymatic activities and higher glycogen content than wild-
type bacteria. aspP was cloned into an expression vector and
introduced into E. coli. Transformed cells were shown to contain a
dramatically reduced amount of glycogen, as compared with the
untransformed bacteria. No pleiotropic changes in the bacterial
growth occurred in both the aspP-overexpressing and aspP-defi-
cient strains. The overall results pinpoint the reaction catalyzed by
ASPPase as a potential step of regulating glycogen biosynthesis in
E. coli.
G lycogen is a branched homopolysaccharide of a-1,4-linkedglucose subunits with a-1,6-linked glucose at the branching
points. Synthesized by glycogen synthase (EC 2.4.1.21) using
ADP-glucose (ADPG) as the sugar donor nucleotide, the accu-
mulation of this polysaccharide in Escherichia coli occurs as a
result of limited growth conditions in the presence of an excess
of a carbon source (1).
Regulation of bacterial glycogen synthesis involves a complex
assemblage of factors that adjust the rate of synthesis according
to the physiological status of the cell. It is generally argued that
these factors affect the gluconeogenic process at the level of
allosteric regulation of the committed step of the pathway,
catalyzed by ADPG pyrophosphorylase (AGPase) (EC 2.7.7.27),
and at the level of regulation of the expression of the genes
encoding gluconeogenic enzymes such as AGPase, phosphoglu-
comutase, glycogen synthase, and the glycogen branching en-
zyme (1, 2).
Recent investigations have demonstrated that glycogen can be
simultaneously synthesized and degraded during bacterial
growth, thus making up a futile cycle wherein AGPase has a dual
role in catalyzing the de novo synthesis of ADPG and in recycling
the glucose units derived from the glycogen breakdown (3–5).
Simultaneous synthesis and degradation of glycogen and starch
have been reported to occur also in animals and plants, respec-
tively (6–10), thus indicating that the operation of futile cycling
may entail advantages such as sensitive regulation and channel-
ing of excess gluconeogenic intermediates toward various met-
abolic pathways in response to physiological and biochemical
needs. In this context, it should be emphasized that nucleotide-
sugar pyrophosphatases from both plants and animals have been
suggested to play a crucial role in diverting carbon flow from
gluconeogenesis to other metabolic pathways (11–13). Accord-
ing to this implicated hypothetical mechanism, the extent to
which both nucleotide-sugars as well as typical gluconeogenic
end products such as starch or glycogen accumulate in the cell
will be inversely correlated to the activities of nucleotide-sugar
hydrolases.
Nucleotide-sugar pyrophosphatases catalyzing the hydrolytic
breakdown of ADPG were first reported to occur in E. coli (14).
The possible involvement of such an activity in the control of
carbon flow toward glycogen has prompted us to identify a
molecular entity, adenosine diphosphate sugar pyrophosphatase
(designated as ASPPase), that hydrolyzes ADPG. Results pre-
sented in this work relating to changes of glycogen content in E.
coli as a result of altered expression of the ASPPase encoding
gene, aspP, strongly indicate that enzymatic breakdown of
ADPG may play a pivotal role in controlling the gluconeogenic
process and in interconnecting gluconeogenesis with other met-
abolic pathways.
Materials and Methods
Bacterial Strains and Culture Media. Purification of ASPPase was
performed by using E. coli BL21 grown in M9 minimal medium
(96 mM Na2HPO4y44 mM KH2PO4y15 mM NaCly35 mM
NH4Cly0.1 mM CaCl2y2 mM MgSO4) supplemented with 5 mM
glucose. All plasmid constructs were electroporated and prop-
agated in E. coli DH5a grown in LB medium with the appro-
priate selection. aspP disruption and overexpression experi-
ments were performed by using BL21 and BL21(DE3) cells,
respectively, that were grown in M9 minimal medium supple-
mented with the indicated amount of glucose. In every case, the
bacteria were grown with rapid gyratory shaking at 37°C after
inoculation with 1 volume of an overnight culture per 100
volumes of fresh medium.
Enzyme Assays. Measurements of ADPG-dependent ASPPase
activities were performed by using the two-step spectrophoto-
metric determination of glucose-1-phosphate described by
Rodrı´guez-Lo´pez et al. (12) to measure plant ADPG pyrophos-
phatase, but with the following modifications. In step one, the
reaction mixture contained 50 mM TriszHCl, pH 7.5y10 mM
MgCl2y2 mM ADPG and protein extract. ADP-ribose- and
ADP-mannose-dependent ASPPase activities were measured by
the chromatographic determination of AMP as described (12).
Abbreviations: ADPG, ADP-glucose; AGPase, ADPG pyrophosphorylase; ASPPase, ADP-
sugar pyrophosphatase.
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The unit is defined as the amount of enzyme that catalyzes the
production of 1 mmol of product per minute. Kinetic parameters
such as Km and Vmax were evaluated by Lineweaver–Burk plots.
ASPPase Purification. For purification of ASPPase, 30 liters of an
overnight grown bacterial culture were centrifuged at 10,000 3
g for 10 min. The pelleted bacteria were then resuspended in 200
ml of extraction buffer (50 mM TriszHCl, pH 7.5), and the
supernatant obtained after sonication and ultracentrifugation at
100,000 3 g for 30 min was heated in a water bath at 58°C for
10 min, cooled on ice, and centrifuged at 30,000 3 g for 30 min.
Proteins from the supernatant (166 ml) were precipitated with
30–50% (NH4)2SO4 and resuspended in 2.7 ml of extraction
buffer. The sample was then subjected to gel filtration on a
Superdex 200 column (Amersham Pharmacia) preequilibrated
with 50 mM TriszHCl, pH 7.5y150 mM NaCl. The partially
purified enzyme was then applied to a Mono-Q column (HR 5 3
5, Amersham Pharmacia) equilibrated with extraction buffer
and eluted with a 45-ml gradient of 0–1 M KCl in 30 mM
TriszHCl, pH 8.0, at a flow rate of 0.75 mlymin. Enzymatically
active fractions were then subjected to isoelectrofocusing sepa-
ration by using a Rotofor Cell apparatus (Bio-Rad).
The molecular mass of the native ASPPase was determined
from a plot of Kav (partition coefficient) versus log molecular
mass of protein standards.
Protein Sequence Analyses. Purified ASPPase was electrophoreti-
cally separated in a 10% SDSyPAGE and blotted onto polyvi-
nylidene difluoride membrane (Immobilon P; Millipore). The
protein band was then excised and used for N-terminal sequenc-
ing analyses with an Applied Biosystems model 473A amino acid
sequencer.
Overexpression and Insertional Disruption of aspP. aspP was ampli-
fied by PCR using the primers 59-GGACATTAACAATGCT-
TAAGCC-39 (forward) and 59-GGTGTGTAACGCTTCATT-
TATGCCCACTC-39 (reverse) and the chromosomal DNA of E.
coli BL21. The 640-bp PCR product obtained was blunt ended
and cloned into the SmaI–EcoRV sites of pBluescript SK2
(Stratagene) to create pASPP.
For aspP overexpression experiments, the HindIII–NotI frag-
ment of pASPP was ligated with the corresponding restriction
sites of the pET-28b(1) expression vector (Novagen) to create
pET-ASPP. E. coli BL21(DE3) transformed with this plasmid
were grown to an absorbance at 600 nm of about 0.6, and then
1 mM isopropyl-b-D-thiogalactopyranoside was added to the
culture medium.
Insertional mutagenesis was carried out by using the chromo-
somal mutagenesis procedure developed by Link et al. (15).
Toward this end, the SmaI cassette of pKT1 (16) containing the
thermostable kanamycin adenyl transferase kat gene was cloned
into the internal SmaI site of pASPP to create pASPPkat. The
NotI–SalI fragment of pASPPkat containing the mutant allele of
aspP was then cloned into the pKO3 gene replacement vector to
create pKO3-ASPPkat, whose cloned fragment was integrated
into the E. coli BL21 chromosome by homologous recombination
with aspP.
Analytical Procedures. Bacterial growth was spectrophotometri-
cally determined by absorbance at 600 nm. Quantitative assay of
biofilm formation was performed as described by O’Toole and
Kolter (17). ASPPase was analyzed for potential cellular local-
ization by using PSORT algorithm (18). Glycogen was deter-
mined by using a glucose oxidase-based test kit (Boehringer
Mannheim). Protein content was measured by the Bradford
method using a Bio-Rad prepared reagent.
Results and Discussion
ASPPase Purification and Characterization. Consistent with the
results of previous investigations reported by Melo and Glaser
(14), preliminary analyses using crude extracts of E. coli revealed
the existence of an enzymatic activity catalyzing the hydrolytic
breakdown of ADPG. We then attempted to purify the enzyme
molecule responsible for this activity. As presented in Table 1,
it was purified over 3,000-fold. SDSyPAGE and subsequent
staining of the purified protein revealed a single band of about
26 kDa (data not shown). The apparent molecular mass of the
native enzyme measured by gel filtration was estimated to be
40–50 kDa, indicating that the enzyme responsible for the
ADPG breakdown is a homodimer.
Substrate specificity was tested by using a wide range of
compounds at a concentration of 5 mM. These preliminary
analyses showed that the enzyme, designated as ASPPase, is a
pyrophosphatase that specifically hydrolyzes adenosine diphos-
phate sugars to produce equimolar amounts of the correspond-
ing sugar monophosphate and AMP (Table 2). ASPPase does
not hydrolyze UDP-glucose, CDP-glucose, GDP-mannose,
adenosine 59-phosphosulfate, PPi, synthetic phosphodiester
bond containing compounds such as bis-p-nitrophenyl-
phosphate, and phosphomonoester bond containing compounds
such as p-nitrophenyl-phosphate, sugar phosphates, and nucle-
oside mono-, di-, and triphosphates.
Essentially similar to the case of other ADPG-cleaving pyro-
phosphatases of plant origin reported (12), ASPPase is a ‘‘reg-
ulatable’’ enzyme that is inhibited by phosphorylated com-
pounds such as AMP, ADP, ATP, 3-phosphoglyceric acid, and
Table 1. Purification of ASPPase from E. coli
Total volume,
ml
Total protein,
mg
Total activity,
milliunits
Specific activity,
milliunitsymg protein
Purification,
-fold
Yield,
%
Crude extract 198 4,206 12,905 3 — 100
Sup. 100,000 3 g (58°C) 166 462 54,499 118 38 422*
Ammonium sulfate 2.7 101 29,719 293 95 155
Superdex 200 15 7.4 19,125 2,584 842 148
Mono-Q 2.7 1.9 6,023 3,170 1,032 47
Isoelectrofocusing 0.6 0.2 1,807 9,511 3,098 15
*Consistent with the results of Melo and Glaser (14), ASPPase in crude extracts of E. coli was shown to be elicidated by mild heating.
Table 2. Substrate specificity of E. coli ASPPase
Substrates Km, mM
VmaxyKm, % with
respect to ADPG
ADPG 167 100
ADP-mannose 183 80
ADP-ribose 125 200
Kitetic parameters (Km and Vmax) are the mean values from five indepen-
dent experiments. ASPPase does not hydrolyze UDP-glucose, GDP-mannose,
adenosine 59-phosphosulfate, and nucleoside mono-, di-, and triphosphates.
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PPi, whereas orthophosphate, a strong inhibitor of the reaction
catalyzed by AGPase, does not exert a substantial inhibitory
effect on ASPPase (data not shown).
Reciprocal Pattern Between ASPPase Activities and Glycogen Content
in E. coli. Glycogen accumulation in E. coli occurs as a result of
limited growth conditions in the presence of an excess of a
carbon source, and it is enhanced as bacterial cultures enter the
stationary phase (1). We have thus examined ASPPase activities
and compared them with the glycogen content in E. coli BL21
grown with different glucose concentrations. As presented in
Fig. 1, the intracellular glycogen contents during the stationary
growth phase correlate well with the amount of glucose in the
culture medium. In sharp contrast, ASPPase activities are high
in cells grown in low glucose concentration in the culture
medium, whereas they decrease dramatically as the glucose
content increases. Despite the limitations inherent in basing
conclusions on in vitro activities, these results showing a glucose-
dependent reciprocal pattern between glycogen content and
ASPPase indicate that, especially under conditions of low carbon
source, the reaction catalyzed by this enzyme may act as a
decisively important limiting step of the gluconeogenic process.
ASPPase Is a Member of the ‘‘Nudix’’ Hydrolases. Purified ASPPase
was subjected to peptide sequencing. Comparison of the 15
amino acids from its N-terminal against sequences existing in the
EMBL data bank showed that ASPPase corresponds to the
product of orf209 (accession number P36651), a member of a
previously characterized group of proteins designated as ‘‘nudix’’
(nucleoside diphosphate linked to some other moiety, X) hy-
drolases that exist in organisms ranging from viruses to mam-
malians, whose suggested role is to cleanse the cell from poten-
tially deleterious endogenous metabolites (19).
Although the product of orf209 remained to be identified in E.
coli, analyses consisting of the systematic expression of nudix
hydrolase-encoding ORFs have revealed that the product of
orf209 is able to hydrolyze ADP-ribose (20). Our results dem-
onstrate that orf209 is indeed a gene, which will be designated as
aspP in this work, encoding an ASPPase.
Insertional Mutagenesis of aspP Induces a Dramatic Reduction of
ADPG Hydrolytic Activities and Increase of Glycogen Content. aspP
was disrupted by insertional mutagenesis, and a comparison of
the ADPG hydrolytic activities and glycogen content between
the mutant and wild-type cells was carried out. As presented
in Fig. 2a, whereas the untransformed cells showed readily
detectable activities, they were almost undetectable in the aspP
knockout mutants in any of the stages of the cell growth. These
results thus demonstrate that most, if not all, ADPG hydrolytic
activity in E. coli is catalyzed by the product of aspP, ASPPase.
Although ASPPase can hydrolyze ADP-ribose (see Table 2),
aspP insertional mutants showed no significant reduction of
ADP-ribose hydrolytic activities (data not shown), which is
ascribable to various enzymes existing in E. coli that catalyze
the hydrolytic breakdown of this nucleotide-sugar (21, 22).
Remarkably, aspP knockout mutants grown in low glucose
concentrations exhibited a significantly higher glycogen con-
tent than the wild-type cells at any stage of the cell growth (Fig.
3a), the overall results thus strongly indicating that the reaction
catalyzed by ASPPase is a limiting step of the gluconeogenic
process.
Enhanced Expression of aspP Results in a Dramatic Reduction of
Intracellular Levels of Glycogen. We then attempted to explore the
effect of increasing ASPPase activities on the glycogen content.
Toward this end, aspP was cloned into the pET-28b(1) expres-
Fig. 1. ASPPase activities and glycogen content in E. coli BL21. Bacteria were
grown in 100 ml of M9 minimal medium supplemented with different glucose
concentrations. Values presented correspond to bacteria entering the station-
ary phase of growth.
Fig. 2. Maximum ASPPase catalytic activities in aspP-overexpressing and
aspP-deficient bacteria. Cells were grown in batch cultures containing 100 ml
of M9 supplemented with 15 mM glucose. At the indicated incubation peri-
ods, the cells were harvested for measurement of ADPG hydrolytic activities.
(a) ASPPase activities in E. coli BL21 and in the aspP knockout mutant. (b)
ASPPase activities in BL21(DE3) bacteria transformed with pET-28b(1) or with
pET-ASPP. Zero time of the incubation time starts when the overnight grown
culture is inoculated to fresh medium.
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sion vector, and the resulting plasmid (pET-ASPP) was used to
transform E. coli BL21(DE3). These cells were found to accu-
mulate an approximate 30-kDa protein that showed kinetic
properties identical to those presented in Table 2 (data not
shown). Furthermore, bacteria transformed with pET-ASPP
exhibited significantly higher ASPPase activities than the control
cells transformed with pET-28b(1) at any stage of the growth
(Fig. 2b).
Cells transformed with pET-28b(1) were shown to accumu-
late detectable amounts of glycogen at any time of their culture.
Following the pattern of glycogen accumulation described in
several bacterial species (4, 5, 23), these cells exhibited a
maximum of their glycogen content when entering into the
stationary phase of growth (Fig. 3b). Most importantly, pET-
ASPP transformants showed a dramatic reduction of glycogen
content at any stage of the cell growth even under conditions of
high glucose concentration in the culture medium (Fig. 3b),
which further strengthens the view that the reaction catalyzed by
ASPPase is a limiting step of the gluconeogenic process.
Changes in aspP Expression Are Not Accompanied by Pleiotropic
Changes in Bacterial Growth, Biofilm Formation, and Activities of
Enzymes Involved in Glycogen Biosynthesis. Mutations affecting the
glycogen biosynthetic process in E. coli have been reported to
occur that are accompanied by changes in cell size, growth,
morphology, surface adherence, and synthesis of exopolysaccha-
rides necessary for biofilm production (23, 24). Therefore, to
explore whether or not aspP mutations may result in such
pleiotropic changes, comparison of the cell growth patterns and
biofilm formation capacities were performed by using both
transformed and untransformed bacteria.
As shown in Fig. 4, both aspP-overexpressing and aspP-
deficient cells exhibited normal growth behavior as compared
with untransformed bacteria, confirming that, as observed in
other mutants with altered glycogen content, this polysaccharide
does not appear to be necessary for bacterial growth (25).
Furthermore, both aspP-overexpressing and aspP-deficient cells
exhibited normal capacities to produce biofilms as compared
with the wild-type bacteria (data not shown), the overall results
thus indicating that the reaction catalyzed by ASPPase is not a
limiting step in the gluconeogenic pathways leading to the
production of exopolysaccharides.
The use of mutants has been proved to be a powerful tool to
establish the currently prevailing schematic pathway of glycogen
biosynthesis, wherein AGPase occupies a decisively important
role (26–28). It must be pointed out, however, that all of these
studies have not been substantially backed up by determining
possible pleiotropic changes in enzymes involved in glycogen
biosynthesis. However, our current ongoing investigations have
clearly demonstrated that aspP mutations described herein do
not affect the activities of enzymes typically considered to be
involved in glycogen biosynthesis (unpublished results).
Additional Remarks. Evidence has been presented that, basically
analogous to the role attributable to ADPG pyrophosphatase in
plants (12), ASPPase may play a role in preventing carbon flow
toward glycogen biosynthesis.
It has been well recognized that futile cycles provide the cell
with a useful regulatory mechanism in the control of the flux
through a metabolic pathway (29). In this context, turnover of
bacterial glycogen has been interpreted by the idea that glycogen
acts as a carbon capacitator that regulates the carbon flow
through glycolysis (4, 5). Essentially in agreement with this
conceptual idea, results presented in this work strongly indicate
that ASPPase may play an important role in connecting the cyclic
gluconeogenic process with other metabolic pathways such as
glycolysis.
Our computer-assisted analyses using the PSORT algorithm
(18) have revealed that ASPPase has characteristics of a typical
cytosolic protein of Gram-negative bacteria (data not shown). It
Fig. 3. Glycogen content in aspP insertional mutants (a) and in aspP-
overexpressing bacteria (b). The cells were grown in the presence of 2 mM and
50 mM glucose, respectively. At the indicated incubation periods, the cells
were harvested for measurement of the glycogen content.
Fig. 4. Nonpleiotropic effect of altered aspP expression on bacterial growth.
Cells were grown in batch cultures containing 100 ml of M9 supplemented
with 50 mM glucose. At the indicated incubation periods, the cells were
harvested for determination of growth (A600) in the BL21 wild-type cells, aspP
knockout mutant, and BL21(DE3) transformed with pET-ASPP or with pET-
28b(1).
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is therefore highly conceivable that, in contrast to other bacterial
nucleotide-sugar pyrophosphatases that act as ‘‘ectoenzymes’’
involved in the scavenging of extracellular nucleotide-sugars (30,
31), ASPPase is in the same compartment of the cell as are the
established processes of ADPG synthesis and utilization. Be-
cause it exhibits high affinity toward ADPG (Table 2), thus
competing with glycogen synthase for the same substrate, it can
be readily predicted that, unless ASPPase is highly regulated,
ADPG will be instantaneously hydrolyzed to produce glucose-
1-phosphate and AMP, thus preventing glycogen biosynthesis.
However ASPPase can be inhibited by nonsubstrate molecules.
Moreover, results presented in Fig. 1 showing a glucose-
dependent reciprocal relationship between ASPPase activities
and glycogen content in E. coli strongly indicate that aspP
expression can be adjusted to the physiological status of the cell.
Needless to say, further research testing possible mechanisms
that regulate the expression of aspP is essential to clarify the
contribution of ASPPase in the control of glycogen biosynthesis
in bacteria.
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